Clinical Trials Logo

Filter by:
NCT ID: NCT02083588 Not yet recruiting - Fibromyalgia Clinical Trials

A Prospective Trial to Explore the Efficacy of dTMS in Subjects With Fibromyalgia

Start date: March 2014
Phase: Phase 2
Study type: Interventional

Fibromyalgia Syndrome (FMS) is a highly prevalent condition often affecting individuals in the prime of life, causing severe reduction in quality of life and productivity, as well as social isolation, anxiety, and depression. The purpose of this study is to explore the efficacy of H1 deep TMS for the treatment of FMS patients. In addition, the investigators attempt to assess the effect of dTMS on the perception and modulation of pain in patients suffering from FMS.

NCT ID: NCT02078505 Not yet recruiting - Clinical trials for Polycystic Ovary Syndrome

Gut Microbiome in Patients With Polycystic Ovary Syndrome

Start date: April 2014
Phase: N/A
Study type: Interventional

The polycystic ovary syndrome is intimately associated with body weight and nutrition.The genomic era did not bring a breakthrough to the understanding of the syndrome. The recent surge of studies on gut microbiome has raised the possibility that the specific diet, which often affect these women favorably, would change their gut microbiome. Hence, the investigators will examine their gut microbial population in comparison to normal ovulatory women and then examine whether a low carbohydrate diet causes favorable change in their gut microbial population.

NCT ID: NCT02077270 Not yet recruiting - Pain Clinical Trials

Pretreatment With Electroacupuncture to Reduce Discomfort

Start date: January 2016
Phase: N/A
Study type: Interventional

The main hypothesis is that performance of electroacupuncture before colonoscopy reduces pain during the exam.

NCT ID: NCT02071316 Not yet recruiting - Mortality Clinical Trials

The Use of Hexacapron in Upper Gastrointestinal Bleeding

HEXUGI
Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a randomized control trial, double-blind study to compare Hexacapron with standard of care treatment to standard of care alone to evaluate the efficacy of adding effect of Hexacapron to standard therapy by decreasing the episodes of rebleeding and mortality in patient with upper gastrointestinal bleeding.

NCT ID: NCT02071186 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

The Effect of Non-pharmacological Novel Cognitive Interventions on Motor-Cognitive Function in Children With ADHD

Start date: March 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test the hypothesis that cognitive remediation and virtual reality treatment approaches can enhance cognitive and motor function in children with ADHD.

NCT ID: NCT02069587 Not yet recruiting - PPROM Clinical Trials

Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes

Start date: February 2014
Phase: N/A
Study type: Interventional

Preterm premature rupture of membrane is associated with increased oxidative stress and inflammatory process, enhancing the activity or the availability of antioxidants may modulate the inflammatory response associated with PPROM, thereby reducing oxidative stress and the risk to the fetus. In this study the investigators sought to determine the effects of Pomegranate 1. On the patients (maternal and fetal) oxidative stress and inflammation associated with PPROM. 2. On the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores

NCT ID: NCT02067546 Not yet recruiting - Constipation Clinical Trials

Innovative Toilet Seat Test for Patients With Symptoms of Constipation and/or Emptying Disorders

constipation
Start date: March 2014
Phase: N/A
Study type: Interventional

Emptying disorders are of the most common causes of constipation. An adjustable toilet seat was designed by " Shva-Nach" Ltd company, and is designed to facilitate the angle sitting position. Its efficacy will be evaluated in the current study, on 50 volunteers who suffer from constipation and meet the Rome 3 criteria for constipation.

NCT ID: NCT02066584 Not yet recruiting - Infertility Clinical Trials

The Influence of Different Concentrations of Glucose in Culture Media on In Vitro Fertilization (IVF) Outcome of Sibling Oocytes

Start date: April 2014
Phase: N/A
Study type: Observational

The importance of glucose in culture media on fertilization and embryo development is still controversial. Although it has been reported that glucose is essential for fertilization process and biosynthesis of membrane lipid and nucleic acids, comparatively high levels of glucose in culture media may cause developmental arrest of cleavage stage embryos. The aim of this retrospective study is to examine whether exposure of sibling oocytes to different concentrations of glucose in culture media has any further effect on IVF outcome.

NCT ID: NCT02066025 Not yet recruiting - Breast Cancer Clinical Trials

Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test

Start date: March 2014
Phase: N/A
Study type: Observational

Octava has two versions, each with a different intend of use. OctavaPink is a qualitative in vitro diagnostic test service, performed by authorized clinical laboratories. The product is used for two following indications: - Intend of Use #1: OctavaPink is indicated for women above 18 years old, who performed mammography and were determined negative for breast cancer. Being moderately sensitive (>55% sensitivity) the test is able to detect 55% of mammography false negatives. In addition, being highly specific (>95% specificity) it supplies additional evidence for true mammography negative result which will reduce examinees anxiety of being misdiagnosed as a result of high false negative mammography rate (10-30%) - Intend of Use #2: OctavaPink is indicated for women above 18 years old, who performed biopsy after positive mammography and the biopsy result was negative. Being moderately sensitive (>55% sensitivity) the test is able to detect 55% of biopsy false negatives. In addition being highly specific (>95% specificity) it supplies an additional evidence for true biopsy negative result which reduces examinees anxiety of being misdiagnosed. OctavBlue is a qualitative in vitro diagnostic test service, performed by EventusDx authorized laboratories. Intend of use of OctavBlue is the following: • OctavBlue is indicated for women above 18 years old, who performed mammography and received doubtful results. Being highly sensitive (>95% sensitivity) the test can help to reveal 95% of positive cases; and being moderately specific (>55% specificity) - about half of negative cases. The test is not intended to be used as a standalone diagnostic technique but to supply additional information to a physician and help deciding about the further course of diagnosis.

NCT ID: NCT02061150 Not yet recruiting - Neonatal Sepsis Clinical Trials

Neonatal Sepsis Workup for High Risk Newborns - Evaluation of Need and Ways to Prevent

Start date: March 2014
Phase: N/A
Study type: Observational

Sepsis is a significant cause of morbidity and mortality among newborns. Due to strict criteria and in order to diagnose and prevent early-onset group B streptococcal (EOGBS) sepsis, many infants undergo a sepsis workup due to risk factors alone, even though they are asymptomatic. Our goal is to evaluate the number of newborns that undergo sepsis workup due to risk factors alone, to determine the number of newborns having positive blood cultures, and to establish ways to reduce the number of asymptomatic infants undergoing sepsis workup.